Global Indian Nasal Spray Market Size study, by Product (Decongestion Nasal Spray, Salt Water Solution/Saline Nasal Spray, Steroid Nasal Spray). by Availability (Prescribed, Over the Counter), by Therapeutic Class (Antihistamine, Nasal Steroids, Mast Cell Inhibitors, Anticholinergic) and by Regional Forecasts 2018-2025
Global Indian Nasal Spray Market to reach USD 1.65 billion by 2025.
Global Indian Nasal Spray Market valued approximately USD 786 million in 2017 is anticipated to grow with a healthy growth rate of more than 9.7% over the forecast period 2018-2025. The primary factors driving the market growth of Indian Nasal include increasing cases of allergic rhinitis and infections, changing lifestyle of people, rising level of pollution, increasing research and development of generic nasal spray drugs, rising awareness among the people, better alternate for other mode of drug delivery, rising demand for self-administration, improving patient compliance, increasing acceptability, and more effective as compared to other forms. About 20-30% of Indian population suffers from at least one allergic disease. On the other hand, addiction to nasal sprays, temporary relief, pungent smell, sneezing, nasal irritation, runny nose, bleeding from nose, and regulatory reforms are some of the major factors which may restraints the growth of nasal spray market.
The regional analysis of Global Indian Nasal Spray Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025
The industry is seeming to be fairly competitive. Some of the leading market players include Glaxo Smith Kline, Ranbaxy., Cipla, Lupin, Sun pharmaceuticals Industries Ltd., Zydus Cadiala Pharmaceuticals, Macleods and so on. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Target Audience of the Global Indian Nasal Spray Market in Market Study:
Global Indian Nasal Spray Market valued approximately USD 786 million in 2017 is anticipated to grow with a healthy growth rate of more than 9.7% over the forecast period 2018-2025. The primary factors driving the market growth of Indian Nasal include increasing cases of allergic rhinitis and infections, changing lifestyle of people, rising level of pollution, increasing research and development of generic nasal spray drugs, rising awareness among the people, better alternate for other mode of drug delivery, rising demand for self-administration, improving patient compliance, increasing acceptability, and more effective as compared to other forms. About 20-30% of Indian population suffers from at least one allergic disease. On the other hand, addiction to nasal sprays, temporary relief, pungent smell, sneezing, nasal irritation, runny nose, bleeding from nose, and regulatory reforms are some of the major factors which may restraints the growth of nasal spray market.
The regional analysis of Global Indian Nasal Spray Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
- Decongestion Nasal Spray
- Salt Water Solution/Saline Nasal Spray
- Steroid Nasal Spray
- Prescribed
- Over the Counter
- Antihistamine
- Nasal Steroids
- Mast Cell Inhibitor
- Anticholinergic
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia Pacific
- China
- India
- Japan
- Latin America
- Brazil
- Mexico
- Rest of the World
Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025
The industry is seeming to be fairly competitive. Some of the leading market players include Glaxo Smith Kline, Ranbaxy., Cipla, Lupin, Sun pharmaceuticals Industries Ltd., Zydus Cadiala Pharmaceuticals, Macleods and so on. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Target Audience of the Global Indian Nasal Spray Market in Market Study:
- Key Consulting Companies & Advisors
- Large, medium-sized, and small enterprises
- Venture capitalists
- Value-Added Resellers (VARs)
- Third-party knowledge providers
- Investment bankers
- Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Million)
1.3.1. Global Indian Nasal Spray Market, by Region, 2015-2025 (USD Million)
1.3.2. Global Indian Nasal Spray Market, by Product, 2015-2025 (USD Million)
1.3.3. Global Indian Nasal Spray Market, by Availability, 2015-2025 (USD Million)
1.3.4. Global Indian Nasal Spray Market, by Therapeutic Class, 2015-2025 (USD Million)
1.4. Estimation Methodology
CHAPTER 2. GLOBAL INDIAN NASAL SPRAY MARKET DEFINITION AND SCOPE
2.1. Research Objective
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL INDIAN NASAL SPRAY MARKET DYNAMICS
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
CHAPTER 4. GLOBAL INDIAN NASAL SPRAY MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Value Chain Analysis
4.3.1. Supplier
4.3.2. Manufacturers/Service Provider
4.3.3. Distributors
4.3.4. End-Users
4.4. Key Buying Criteria
4.5. Regulatory Framework
4.6. Cost Structure Analysis
4.6.1. Raw Material Cost Analysis
4.6.2. Manufacturing Cost Analysis
4.6.3. Labour Cost Analysis
4.7. Investment Vs Adoption Scenario
4.8. Analyst Recommendation & Conclusion
CHAPTER 5. INDIAN NASAL SPRAY MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Indian Nasal Spray Market, Sub Segment Analysis
5.3.1. Decongestion Nasal Spray
5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Million)
5.3.2. Salt Water Solution/Saline Nasal Spray
5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Million)
5.3.3. Steroid Nasal Spray
5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Million)
CHAPTER 6. INDIAN NASAL SPRAY MARKET, BY AVAILABILITY
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Indian Nasal Spray Market, Sub Segment Analysis
6.3.1. Prescribed
6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Million)
6.3.2. Over the Counter
6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Million)
CHAPTER 7. INDIAN NASAL SPRAY MARKET, BY THERAPEUTIC CLASS
7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Indian Nasal Spray Market, Sub Segment Analysis
7.3.1. Antihistamine
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Million)
7.3.2. Nasal Steroids
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Million)
7.3.3. Mast Cell Inhibitor
7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Million)
7.3.4. Anticholinergic
7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Million)
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Company Market Share (Subject to Data Availability)
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. GlaxoSmithKline
8.3.1.1. Overview
8.3.1.2. Financial (Subject to Data Availability)
8.3.1.3. Product Summary
8.3.1.4. Recent Developments
8.3.2. Ranbaxy.
8.3.3. Cipla
8.3.4. Lupin
8.3.5. Sun pharmaceuticals Industries Ltd.
8.3.6. Zydus Cadiala Pharmaceuticals
8.3.7. Macleods
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Million)
1.3.1. Global Indian Nasal Spray Market, by Region, 2015-2025 (USD Million)
1.3.2. Global Indian Nasal Spray Market, by Product, 2015-2025 (USD Million)
1.3.3. Global Indian Nasal Spray Market, by Availability, 2015-2025 (USD Million)
1.3.4. Global Indian Nasal Spray Market, by Therapeutic Class, 2015-2025 (USD Million)
1.4. Estimation Methodology
CHAPTER 2. GLOBAL INDIAN NASAL SPRAY MARKET DEFINITION AND SCOPE
2.1. Research Objective
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL INDIAN NASAL SPRAY MARKET DYNAMICS
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
CHAPTER 4. GLOBAL INDIAN NASAL SPRAY MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Value Chain Analysis
4.3.1. Supplier
4.3.2. Manufacturers/Service Provider
4.3.3. Distributors
4.3.4. End-Users
4.4. Key Buying Criteria
4.5. Regulatory Framework
4.6. Cost Structure Analysis
4.6.1. Raw Material Cost Analysis
4.6.2. Manufacturing Cost Analysis
4.6.3. Labour Cost Analysis
4.7. Investment Vs Adoption Scenario
4.8. Analyst Recommendation & Conclusion
CHAPTER 5. INDIAN NASAL SPRAY MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Indian Nasal Spray Market, Sub Segment Analysis
5.3.1. Decongestion Nasal Spray
5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Million)
5.3.2. Salt Water Solution/Saline Nasal Spray
5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Million)
5.3.3. Steroid Nasal Spray
5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Million)
CHAPTER 6. INDIAN NASAL SPRAY MARKET, BY AVAILABILITY
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Indian Nasal Spray Market, Sub Segment Analysis
6.3.1. Prescribed
6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Million)
6.3.2. Over the Counter
6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Million)
CHAPTER 7. INDIAN NASAL SPRAY MARKET, BY THERAPEUTIC CLASS
7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Indian Nasal Spray Market, Sub Segment Analysis
7.3.1. Antihistamine
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Million)
7.3.2. Nasal Steroids
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Million)
7.3.3. Mast Cell Inhibitor
7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Million)
7.3.4. Anticholinergic
7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Million)
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Company Market Share (Subject to Data Availability)
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. GlaxoSmithKline
8.3.1.1. Overview
8.3.1.2. Financial (Subject to Data Availability)
8.3.1.3. Product Summary
8.3.1.4. Recent Developments
8.3.2. Ranbaxy.
8.3.3. Cipla
8.3.4. Lupin
8.3.5. Sun pharmaceuticals Industries Ltd.
8.3.6. Zydus Cadiala Pharmaceuticals
8.3.7. Macleods
